tryptophan has been researched along with reboxetine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charney, DS | 1 |
| Aubin, N; Avenet, P; Bougault, I; Busch, S; Chen, Y; Claustre, Y; Desvignes, C; Didier, M; Keane, P; Le Fur, G; Leonetti, M; Oury-Donat, F; Palejwala, V; Rouquier, L; Santucci, V; Scatton, B; Steinberg, R; Tocci, M; Yamdagni, P | 1 |
1 review(s) available for tryptophan and reboxetine
| Article | Year |
|---|---|
Monoamine dysfunction and the pathophysiology and treatment of depression.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Carrier Proteins; Catecholamines; Cocaine; Depressive Disorder; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Morpholines; Nerve Tissue Proteins; Neuropeptides; Norepinephrine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon; Tryptophan | 1998 |
1 other study(ies) available for tryptophan and reboxetine
| Article | Year |
|---|---|
Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profile.
Topics: Action Potentials; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Brain; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Fluoxetine; Male; Mice; Microdialysis; Morpholines; Motor Activity; Neurons; Norepinephrine; Rats; Reboxetine; Receptors, Adrenergic, beta-2; Selective Serotonin Reuptake Inhibitors; Serotonin; Tetrahydronaphthalenes; Tryptophan | 2008 |